Patients at risk of recurrent blood clots can now be offered an alternative to warfarin, which some patients find inconvenient due to the need for careful monitoring and regular visits to clinics for blood tests.
According to the latest guidance from NICE, patients can now be offered dabigatran etexilate to prevent recurring DVT and pulmonary embolism in adults.